Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 2 of 3: Mean cell count and mean normalized growth rate inhibition values across all replicates. - Dataset (ID:20257)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| BT-20 | Taxol | 0.01 | uM | 3 | 156.25 | 49.48 | 63.67 | 96.33 | 0.6492 | 0.2446 |
| BT-20 | Taxol | 0.031623 | uM | 3 | 156.25 | 49.48 | 61.67 | 96.33 | 0.6418 | 0.2467 |
| BT-20 | Taxol | 0.1 | uM | 3 | 156.25 | 49.48 | 57.00 | 96.33 | 0.5966 | 0.1596 |
| BT-20 | Taxol | 0.31623 | uM | 3 | 156.25 | 49.48 | 54.67 | 96.33 | 0.5671 | 0.0910 |
| BT-20 | Taxol | 1 | uM | 3 | 156.25 | 49.48 | 46.00 | 96.33 | 0.4801 | -0.0811 |
| BT-20 | Etoposide | 0.0033113 | uM | 3 | 156.25 | 49.48 | 121.33 | 104.50 | 1.1629 | 1.3007 |
| BT-20 | Etoposide | 0.01 | uM | 3 | 156.25 | 49.48 | 129.00 | 104.50 | 1.2308 | 1.4154 |
| BT-20 | Etoposide | 0.031623 | uM | 3 | 156.25 | 49.48 | 98.00 | 104.50 | 0.9340 | 0.8663 |
| BT-20 | Etoposide | 0.1 | uM | 3 | 156.25 | 49.48 | 133.67 | 104.50 | 1.2854 | 1.5413 |
| BT-20 | Etoposide | 0.31623 | uM | 3 | 156.25 | 49.48 | 115.67 | 104.50 | 1.1087 | 1.2053 |
| BT-20 | Etoposide | 1 | uM | 3 | 156.25 | 49.48 | 95.67 | 104.50 | 0.9202 | 0.8608 |
| BT-20 | Etoposide | 3.1623 | uM | 3 | 156.25 | 49.48 | 94.33 | 104.50 | 0.8976 | 0.7957 |
| BT-20 | Etoposide | 10 | uM | 3 | 156.25 | 49.48 | 73.67 | 104.50 | 0.7028 | 0.4339 |
| BT-20 | Etoposide | 19.9526 | uM | 3 | 156.25 | 49.48 | 57.00 | 104.50 | 0.5472 | 0.1434 |
| BT-20 | Nilotinib | 0.0033113 | uM | 3 | 156.25 | 49.48 | 129.33 | 104.50 | 1.2411 | 1.4525 |
| BT-20 | Nilotinib | 0.01 | uM | 3 | 156.25 | 49.48 | 120.33 | 104.50 | 1.1556 | 1.2992 |
| BT-20 | Nilotinib | 0.031623 | uM | 3 | 156.25 | 49.48 | 89.00 | 104.50 | 0.8519 | 0.7234 |
| BT-20 | Nilotinib | 0.1 | uM | 3 | 156.25 | 49.48 | 76.67 | 104.50 | 0.7362 | 0.5086 |
| BT-20 | Nilotinib | 0.31623 | uM | 3 | 156.25 | 49.48 | 93.00 | 104.50 | 0.8966 | 0.8197 |
| BT-20 | Nilotinib | 1 | uM | 3 | 156.25 | 49.48 | 141.67 | 104.50 | 1.3597 | 1.6738 |
| BT-20 | Nilotinib | 3.1623 | uM | 3 | 156.25 | 49.48 | 123.00 | 104.50 | 1.1788 | 1.3359 |
| BT-20 | Nilotinib | 10 | uM | 3 | 156.25 | 49.48 | 561.00 | 104.50 | 5.3308 | 8.3042 |
| BT-20 | Nilotinib | 19.9526 | uM | 3 | 156.25 | 49.48 | 1106.67 | 104.50 | 10.6186 | 17.3422 |
| BT-20 | PLX-4720 | 0.0033113 | uM | 3 | 156.25 | 49.48 | 124.00 | 104.50 | 1.1879 | 1.3474 |
| BT-20 | PLX-4720 | 0.01 | uM | 3 | 156.25 | 49.48 | 115.00 | 104.50 | 1.1058 | 1.2097 |